Amount Raised
$24 Million
Round Type
Funding Round
San FranciscoBiotechnologyHealth CareScience And EngineeringDescription
PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as PostEra Inc. that raised within 45 days of this round, from Fundz verified event records.
- Synthego Corp raised $200M (Funding Round) on February 17, 2022.
- Walking Fish Therapeutics raised $73M (Series A) on February 16, 2022.
- Memo Therapeutics AG raised an undisclosed amount (Series B) on February 16, 2022.
- Electra Therapeutics raised $84M (Series B) on February 16, 2022.
- Variantyx raised $42M (Funding Round) on February 14, 2022.
- Arkuda Therapeutics raised $64M (Series B) on February 10, 2022.
Who to call at PostEra Inc., and when
A new round usually means PostEra Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PostEra Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PostEra Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PostEra Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PostEra Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
PostEra Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.